Filing Flows › Comparisons › AZN vs BMY
AstraZeneca vs Bristol Myers Squibb: AZN and BMY compared
AstraZeneca is the larger company: $14.5B of revenue in its latest quarter (Q2 2025) against $13.1B for Bristol Myers Squibb (Q3 2026). AstraZeneca is growing faster (+12% against +7% a year earlier). AstraZeneca is more profitable, with an operating margin of 24.3% against 19.4%.
Where the money goes: AZN and BMY
AstraZeneca (AZN) · Q2 2025
AstraZeneca, Q2 2025: revenue $14.5B (+12% year over year), operating margin 24.3%, net earnings $2.4B. The chart follows the revenue to costs, profit and cash.
Bristol Myers Squibb (BMY) · Q3 2026
Bristol Myers Squibb, Q3 2026: revenue $13.1B (+7% year over year), operating margin 19.4%, net earnings $2.2B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
| AstraZeneca (AZN) | Bristol Myers Squibb (BMY) | |
|---|---|---|
| Latest quarter | Q2 2025 | Q3 2026 |
| Revenue | $14.5B | $13.1B |
| Revenue growth, Y/Y | +12% | +7% |
| Gross margin | 82.9% | — |
| Operating margin | 24.3% | 19.4% |
| Net earnings | $2.4B | $2.2B |
| Net margin | 16.9% | 16.5% |
| Operating cash flow | — | $4.2B |
| Free cash flow | — | $3.8B |
| Market value | $289.1B | $127.6B |
| P/E | 28.3× | 13.7× |
| Analysts’ mean target | $208.07 | $65.25 |
Where the revenue comes from
AstraZeneca
- Product Revenue: $14.4B (100%)
- Collaboration Revenue: $8.0M (0%)
Bristol Myers Squibb
- Net product sales: $12.6B (97%)
- Camzyos: $420M (3%)
Questions
Which is bigger, AstraZeneca or Bristol Myers Squibb?
AstraZeneca is the larger company: $14.5B of revenue in its latest quarter (Q2 2025) against $13.1B for Bristol Myers Squibb (Q3 2026).
Is AstraZeneca or Bristol Myers Squibb growing faster?
AstraZeneca is growing faster (+12% against +7% a year earlier).
Which is more profitable, AstraZeneca or Bristol Myers Squibb?
AstraZeneca is more profitable, with an operating margin of 24.3% against 19.4%.
More: AstraZeneca earnings · how AstraZeneca makes money · Bristol Myers Squibb earnings · how Bristol Myers Squibb makes money
From the companies' latest 10-Q, 10-K or earnings release (6-K filed Jul 29, 2025; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.